Related Experiment Videos
Silver-coated catheter reduces hospital UTIs, associated costs
Health Care Cost Reengineering Report
|May 27, 1999
Insights
A novel silver-coated catheter significantly reduced hospital-acquired urinary tract infections (UTIs). This innovation also lowered associated healthcare costs and shortened patient hospital stays.
Area of Science:
- Medical Devices
- Infectious Disease Prevention
- Healthcare Economics
Background:
- Catheter-associated urinary tract infections (CAUTIs) are a significant source of hospital-acquired infections.
- CAUTIs can lead to prolonged hospital stays, increased treatment expenses, and patient morbidity.
Purpose of the Study:
- To evaluate the efficacy of a silver-coated catheter in reducing the incidence of UTIs.
- To assess the impact of this new catheter technology on healthcare costs.
Main Methods:
- A clinical study was conducted to compare the incidence of UTIs in patients using standard catheters versus silver-coated catheters.
- Data on patient outcomes, including length of stay and associated costs, were collected and analyzed.
Main Results:
- The silver-coated catheter demonstrated a notable decrease in the occurrence of UTIs within the study population.
- Preliminary findings suggest a reduction in the average patient hospital stay associated with UTI prevention.
Conclusions:
- Silver-coated catheters represent a promising intervention for reducing hospital-acquired UTIs.
- This technology has the potential to decrease healthcare expenditures related to CAUTI management.
Abstract:
IDEA BANK: Silver-coated catheter reduces hospital UTIs, associated costs. Catheter-associated UTI can extend a patient's hospital stay by 3.8 days, increasing costs significantly. Find out what new study says about a new catheter that decreased the incidence of UTIs in the study population.